1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Wang, G. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 51 653 664 10.1021/bi2016266 22185690 Structure, Dynamics, and Antimicrobial and Immune Modulatory Activities of Human LL-23 and Its Single-Residue Variants Mutated on the Basis of Homologous Primate Cathelicidins. 2012 10.2210/pdb2lmf/pdb pdb_00002lmf 2831.405 Antibacterial protein LL-37 UNP residues 134-156 1 syn polymer Cathelicidin antimicrobial peptide no no LLGDFFRKSKEKIGKEFKRIVQR LLGDFFRKSKEKIGKEFKRIVQR A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n database_2 pdbx_database_status pdbx_nmr_software repository Initial release Database references Data collection Database references Other 1 0 2011-12-28 1 1 2012-02-08 1 2 2023-06-14 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.status_code_nmr_data _pdbx_nmr_software.name LL-37 BMRB Y RCSB 2011-11-30 REL REL REL REL 9606 human Homo sapiens sample structures with the lowest energy 100 20 2D 1H-15N HSQC 2D 1H-13C HSQC aliphatic 2D 1H-1H NOESY 2D 1H-1H TOCSY 2D DQF-COSY 2D 1H-13C HSQC aromatic 2 mM unbuffered 6 ambient 310 K simulated annealing 1 lowest energy 2 mM LL, 100% D2O 100% D2O Schwieters, Kuszewski, Tjandra and Clore structure solution X-PLOR NIH Schwieters, Kuszewski, Tjandra and Clore refinement X-PLOR NIH 600 Varian INOVA Varian INOVA 400 Bruker DMX Bruker DMX LEU 1 n 1 LEU 1 A LEU 2 n 2 LEU 2 A GLY 3 n 3 GLY 3 A ASP 4 n 4 ASP 4 A PHE 5 n 5 PHE 5 A PHE 6 n 6 PHE 6 A ARG 7 n 7 ARG 7 A LYS 8 n 8 LYS 8 A SER 9 n 9 SER 9 A LYS 10 n 10 LYS 10 A GLU 11 n 11 GLU 11 A LYS 12 n 12 LYS 12 A ILE 13 n 13 ILE 13 A GLY 14 n 14 GLY 14 A LYS 15 n 15 LYS 15 A GLU 16 n 16 GLU 16 A PHE 17 n 17 PHE 17 A LYS 18 n 18 LYS 18 A ARG 19 n 19 ARG 19 A ILE 20 n 20 ILE 20 A VAL 21 n 21 VAL 21 A GLN 22 n 22 GLN 22 A ARG 23 n 23 ARG 23 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A A O H ILE PHE 13 17 1.37 1 A A O H PHE LYS 6 10 1.40 1 A A O H SER ILE 9 13 1.57 2 A A O H ILE PHE 13 17 1.32 2 A A O H PHE LYS 6 10 1.36 2 A A O H GLU ILE 16 20 1.46 2 A A O H LEU PHE 2 5 1.60 3 A A O H ILE PHE 13 17 1.33 3 A A O H PHE LYS 6 10 1.43 3 A A O H LEU PHE 2 5 1.52 3 A A O H SER ILE 9 13 1.52 4 A A O H ILE PHE 13 17 1.32 4 A A O H PHE LYS 6 10 1.39 4 A A O H LEU PHE 2 5 1.54 4 A A O H PHE VAL 17 21 1.59 5 A A O H ILE PHE 13 17 1.35 5 A A O H PHE LYS 6 10 1.42 5 A A O H LEU PHE 2 5 1.49 6 A A O H ILE PHE 13 17 1.32 6 A A O H PHE LYS 6 10 1.41 6 A A O H SER ILE 9 13 1.55 6 A A O H LEU PHE 2 5 1.59 7 A A O H ILE PHE 13 17 1.31 7 A A O H PHE LYS 6 10 1.44 7 A A O H GLU ILE 16 20 1.53 7 A A O H LEU PHE 2 5 1.54 8 A A O H ILE PHE 13 17 1.32 8 A A O H PHE LYS 6 10 1.39 8 A A O H LEU PHE 2 5 1.50 9 A A O H PHE LYS 6 10 1.34 9 A A O H ILE PHE 13 17 1.36 9 A A O H PHE VAL 17 21 1.44 9 A A O H LEU PHE 2 5 1.57 10 A A O H ILE PHE 13 17 1.37 10 A A O H PHE LYS 6 10 1.42 11 A A O H ILE PHE 13 17 1.33 11 A A O H PHE LYS 6 10 1.40 11 A A O H GLU ILE 16 20 1.55 11 A A O H LEU PHE 2 5 1.55 12 A A O H ILE PHE 13 17 1.36 12 A A O H PHE LYS 6 10 1.48 12 A A O H LYS GLY 10 14 1.51 13 A A O H ILE PHE 13 17 1.32 13 A A O H PHE LYS 6 10 1.35 13 A A O H LEU PHE 2 5 1.56 13 A A O H SER ILE 9 13 1.59 14 A A O H ILE PHE 13 17 1.33 14 A A O H PHE LYS 6 10 1.40 14 A A O H LEU PHE 2 5 1.51 14 A A O H GLU ILE 16 20 1.52 14 A A O H SER ILE 9 13 1.59 15 A A O H ILE PHE 13 17 1.33 15 A A O H PHE LYS 6 10 1.44 15 A A O H LEU PHE 2 5 1.53 15 A A O H LYS GLY 10 14 1.59 16 A A O H ILE PHE 13 17 1.37 16 A A O H PHE LYS 6 10 1.45 17 A A O H PHE LYS 6 10 1.39 17 A A O H ILE PHE 13 17 1.45 17 A A O H LEU PHE 2 5 1.47 18 A A O H ILE PHE 13 17 1.34 18 A A O H PHE LYS 6 10 1.41 19 A A O H PHE LYS 6 10 1.32 19 A A O H ILE PHE 13 17 1.39 20 A A O H ILE PHE 13 17 1.32 20 A A O H PHE LYS 6 10 1.35 20 A A O H VAL ARG 21 23 1.56 20 A A O H PHE VAL 17 21 1.59 1 A VAL 21 -93.90 44.83 1 A GLN 22 -62.82 77.74 3 A VAL 21 -114.98 70.88 5 A VAL 21 -98.23 53.16 6 A VAL 21 -84.20 37.49 6 A GLN 22 -43.75 88.78 7 A GLN 22 21.68 35.92 8 A VAL 21 -112.83 69.30 9 A GLN 22 -66.99 64.62 10 A VAL 21 -85.76 30.37 10 A GLN 22 28.68 60.16 11 A VAL 21 -105.03 55.46 11 A GLN 22 -63.15 88.54 12 A GLN 22 -156.96 15.59 14 A GLN 22 -5.52 73.90 15 A VAL 21 -116.66 65.56 16 A VAL 21 -82.09 35.26 16 A GLN 22 -43.04 89.02 17 A GLN 22 -63.28 69.00 18 A GLN 22 -39.08 83.74 19 A GLN 22 -49.16 87.51 20 A VAL 21 -96.65 54.69 20 A GLN 22 -68.23 43.02 lowest energy, model 20 Solution structure of human LL-23 bound to membrane-mimetic micelles 1 N N A LEU 1 A LEU 1 HELX_P A VAL 21 A VAL 21 1 1 21 ANTIMICROBIAL PROTEIN antimicrobial and innate immune modulating peptide, ANTIMICROBIAL PROTEIN CAMP_HUMAN UNP 1 134 P49913 LLGDFFRKSKEKIGKEFKRIVQR 134 156 2LMF 1 23 P49913 A 1 1 23